Patent · US Active

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

US9532998B2 · kind B2 · utility

1Cited by

52References

24Claims

0Family size

Assignee

Rigel Pharmaceuticals, Inc. · US

Inventors

Rajinder Singh · Belmont, US
Somasekhar Bhamidipati · Foster City, US
Esteban Masuda · Menlo Park, US
Thomas Sun · Fremont, US
Valentino J. Stella · Lawrence, US

Key dates

Filing date	Jan 13, 2016
Grant date	Jan 3, 2017
Priority date	—
Expiry date	Jan 13, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/65742
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.